These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Characterization of the peripheral FAAH inhibitor, URB937, in animal models of acute and chronic migraine. Greco R, Demartini C, Zanaboni A, Casini I, De Icco R, Reggiani A, Misto A, Piomelli D, Tassorelli C. Neurobiol Dis; 2021 Jan; 147():105157. PubMed ID: 33129939 [Abstract] [Full Text] [Related]
8. FAAH inhibition as a preventive treatment for migraine: A pre-clinical study. Greco R, Demartini C, Zanaboni AM, Tumelero E, Reggiani A, Misto A, Piomelli D, Tassorelli C. Neurobiol Dis; 2020 Feb; 134():104624. PubMed ID: 31629892 [Abstract] [Full Text] [Related]
9. Alterations of the endocannabinoid system in an animal model of migraine: evaluation in cerebral areas of rat. Greco R, Gasperi V, Sandrini G, Bagetta G, Nappi G, Maccarrone M, Tassorelli C. Cephalalgia; 2010 Mar; 30(3):296-302. PubMed ID: 19515121 [Abstract] [Full Text] [Related]
12. The role of the transient receptor potential ankyrin type-1 (TRPA1) channel in migraine pain: evaluation in an animal model. Demartini C, Tassorelli C, Zanaboni AM, Tonsi G, Francesconi O, Nativi C, Greco R. J Headache Pain; 2017 Sep 07; 18(1):94. PubMed ID: 28884307 [Abstract] [Full Text] [Related]
13. Distinct Activity of Endocannabinoid-Hydrolyzing Enzymes MAGL and FAAH in Key Regions of Peripheral and Central Nervous System Implicated in Migraine. Della Pietra A, Giniatullin R, Savinainen JR. Int J Mol Sci; 2021 Jan 26; 22(3):. PubMed ID: 33530477 [Abstract] [Full Text] [Related]
17. The dual FAAH/MAGL inhibitor JZL195 has enhanced effects on endocannabinoid transmission and motor behavior in rats as compared to those of the MAGL inhibitor JZL184. Seillier A, Dominguez Aguilar D, Giuffrida A. Pharmacol Biochem Behav; 2014 Sep 23; 124():153-9. PubMed ID: 24911644 [Abstract] [Full Text] [Related]
18. Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment. Guindon J, Lai Y, Takacs SM, Bradshaw HB, Hohmann AG. Pharmacol Res; 2013 Jan 23; 67(1):94-109. PubMed ID: 23127915 [Abstract] [Full Text] [Related]
19. Inhibitors of monoacylglycerol lipase, fatty-acid amide hydrolase and endocannabinoid transport differentially suppress capsaicin-induced behavioral sensitization through peripheral endocannabinoid mechanisms. Spradley JM, Guindon J, Hohmann AG. Pharmacol Res; 2010 Sep 23; 62(3):249-58. PubMed ID: 20416378 [Abstract] [Full Text] [Related]
20. Dual blockade of FAAH and MAGL identifies behavioral processes regulated by endocannabinoid crosstalk in vivo. Long JZ, Nomura DK, Vann RE, Walentiny DM, Booker L, Jin X, Burston JJ, Sim-Selley LJ, Lichtman AH, Wiley JL, Cravatt BF. Proc Natl Acad Sci U S A; 2009 Dec 01; 106(48):20270-5. PubMed ID: 19918051 [Abstract] [Full Text] [Related] Page: [Next] [New Search]